✦ LIBER ✦

Clinical significance of minimal residual disease in childhood acute myeloid leukemia

✍ Scribed by Takako Miyamura; Naoki Sakata; Takayuki Okamura; Masahiro Yasui; Masami Inoue; Keiko Yagi; Masahiro Sako; Yoshihiro Komada; Takaharu Matsuyama; Megumi Oda; Yong -Dong Park; Keisei Kawa

Book ID: 111835290
Publisher: Carden Jennings Publishing
Year: 2004
Tongue: English
Weight: 144 KB
Volume: 79
Category: Article
ISSN: 0925-5710
DOI: 10.1532/ijh97.03113

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Significance of Minimal Residua

Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia

✍ Cavé, Hélène; van der Werff ten Bosch, Jutte; Suciu, Stefan; Guidal, Christine; 📂 Article 📅 1998 🏛 Massachusetts Medical Society 🌐 English ⚖ 119 KB

Clinical significance of minimal residua

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse

✍ Coustan-Smith, E; Gajjar, A; Hijiya, N; Razzouk, B I; Ribeiro, R C; Rivera, G K; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 132 KB

Clinical significance of minimal residua

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse

✍ von Stackelberg, A; Seeger, K; Henze, G; Eckert, C 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 62 KB

Minimal Residual Disease Quantitation in

Minimal Residual Disease Quantitation in Acute Myeloid Leukemia

✍ Shook, David; Coustan-Smith, Elaine; Ribeiro, Raul C.; Rubnitz, Jeffrey E.; Camp 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 114 KB

Clinical significance of minimal residua

Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia

✍ Misato Kikuchi; Junji Tanaka; Takeshi Kondo; Satoshi Hashino; Masaharu Kasai; Mi 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 276 KB

Monitoring of minimal residual disease i

Monitoring of minimal residual disease in acute myeloid leukemia

✍ Wolfgang Kern; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 587 KB

## Abstract Two highly sensitive methods, multiparameter flow cytometry (MFC) and real‐time quantitative PCR (RQ‐PCR), are increasingly used to monitor minimal residual disease (MRD) and to guide risk‐adapted management in acute myeloid leukemia (AML). An independent prognostic impact has been demo